360 High-Risk Vulnerability Immunization Tool V2.0 vs OneTrust Consent Management Platform (CMP): Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

OneTrust Consent Management Platform (CMP): Consent management platform for capturing user consent across digital channels. built by OneTrust, LLC. Core capabilities include Automated cookie, SDK, and tracker discovery and categorization, Customizable consent banners and preference centers with geolocation awareness, No-code script blocking until consent is received..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. OneTrust Consent Management Platform (CMP) differentiates with Automated cookie, SDK, and tracker discovery and categorization, Customizable consent banners and preference centers with geolocation awareness, No-code script blocking until consent is received.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). OneTrust Consent Management Platform (CMP) is developed by OneTrust, LLC. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and OneTrust Consent Management Platform (CMP) serve similar Endpoint Protection Platform use cases. Review the feature comparison above to determine which fits your requirements.